Omer Aras
An in-vivo pilot study into the effects of FDG-mNP in cancer in mice
Aras, Omer; Pearce, Gillian; Watkins, Adam J.; Nurili, Fuad; Medine, Emin Ilker; Guldu, Ozge Kozgus; Tekin, Volkan; Wong, Julian; Ma, Xianghong; Ting, Richard; Unak, Perihan; Akin, Oguz
Authors
Gillian Pearce
Adam J. Watkins
Fuad Nurili
Emin Ilker Medine
Ozge Kozgus Guldu
Volkan Tekin
Julian Wong
Xianghong Ma
Richard Ting
Perihan Unak
Oguz Akin
Contributors
Bing Xu
Editor
Abstract
PURPOSE:
Previously, fluorodeoxy glucose conjugated magnetite nanoparticles (FDG-mNPs) injected into cancer cells in conjunction with the application of magnetic hyperthermia have shown promise in new FDG-mNPs applications. The aim of this study was to determine potential toxic or unwanted effects involving both tumour cells and normal tissue in other organs when FDG-mNPs are administered intravenously or intratumourally in mice.
MATERIALS AND METHODS:
FDG-mNPs were synthesized. A group of six prostate-tumour bearing mice were injected with 23.42 mg/ml FDG-mNPs (intravenous injection, n = 3; intratumoural injection into the prostate tumour, n = 3). Mice were euthanized and histological sampling of tissue was conducted for the prostate tumour, as well as for lungs, lymph nodes, liver, kidneys, spleen, and brain, at 1 hour (n = 2) and 7 days (n = 4) post-injection. A second group of two normal (non-cancerous) mice received the same injection intravenously into the tail vein and were euthanised at 3 and 6 months post-injection, respectively, to investigate if FDG-mNPs remained in organs at those time points.
RESULTS:
In prostate-tumour bearing mice, FDG-mNPs concentrated in the prostate tumour, while relatively small amounts were found in the organs of other tissues, particularly the spleen and the liver; FDG-mNP concentrations decreased over time in all tissues. In normal mice, no detrimental effects were found in either mouse at 3 or 6 months.
CONCLUSION:
Intravenous or intratumoural FDG-mNPs can be safely administered for effective cancer cell destruction. Further research on the clinical utility of FDG-mNPs will be conducted by applying hyperthermia in conjunction with FDG-mNPs in mice.
Citation
Aras, O., Pearce, G., Watkins, A. J., Nurili, F., Medine, E. I., Guldu, O. K., Tekin, V., Wong, J., Ma, X., Ting, R., Unak, P., & Akin, O. (2018). An in-vivo pilot study into the effects of FDG-mNP in cancer in mice. PLoS ONE, 13(8), Article e0202482. https://doi.org/10.1371/journal.pone.0202482
Journal Article Type | Article |
---|---|
Acceptance Date | Aug 10, 2018 |
Online Publication Date | Aug 20, 2018 |
Publication Date | Aug 21, 2018 |
Deposit Date | Aug 21, 2018 |
Publicly Available Date | Aug 21, 2018 |
Journal | PLOS ONE |
Publisher | Public Library of Science |
Peer Reviewed | Peer Reviewed |
Volume | 13 |
Issue | 8 |
Article Number | e0202482 |
DOI | https://doi.org/10.1371/journal.pone.0202482 |
Keywords | General Biochemistry, Genetics and Molecular Biology; General Agricultural and Biological Sciences; General Medicine |
Public URL | https://nottingham-repository.worktribe.com/output/1040923 |
Publisher URL | http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0202482 |
Contract Date | Aug 21, 2018 |
Files
journal.pone.0202482
(23.4 Mb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/publicdomain
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search